Top Pharma Stocks in India

Updated 21 Nov 2026

Summary

Based on the latest available market data, the top five stocks in Pharma Stocks in India are Jupiter Life Line Hospitals Ltd., Sigachi Industries Ltd., Nureca Ltd., Apollo Hospitals Enterprise Ltd., and Sakar Healthcare Ltd. This list is prepared using factors such as market capitalisation, trading volume, recent performance, valuation and liquidity. The selection factors may vary depending on the stock category.

List of Top Pharma Stocks in India

Prices and ratios reflect the latest available market data from 21 November 2026

Scroll horizontally to see all columns on smaller screens.

Company NameSectorCMP (₹)1-Day Change (%)VolumeP/E (TTM)Industry P/EMkt Cap (₹ Cr)EPS TTM (₹)52W High52W Low1-Yr ReturnROE (%)ROCE (%)
Jupiter Life Line Hospitals Ltd.Jupiter Life Line Hospitals Ltd.Healthcare316.32+14.371,87,11,86355.665.910,4005.69334.13231.43+9.813.415.7
Sigachi Industries Ltd.Sigachi Industries Ltd.Healthcare30.26+11.131,57,98,02646.641.91,1620.6540.3116.43-13.4-14.8-10.7
Nureca Ltd.Nureca Ltd.Healthcare310.33+5.3113,22764.5129.82964.81372.26201.54+15.91.13.3
Apollo Hospitals Enterprise Ltd.Apollo Hospitals Enterprise Ltd.Healthcare9,102.75+5.2214,12,62258.465.91,32,139155.939,186.536,582.80+23.923.521.7
Sakar Healthcare Ltd.Sakar Healthcare Ltd.Healthcare1,015.84+5.091,53,09252.741.92,27719.271,220.71347.46+161.010.012.5
Vijaya Diagnostic Centre Ltd.Vijaya Diagnostic Centre Ltd.Healthcare1,552.50+4.755,38,52178.465.916,18619.801,572.13831.02+48.519.930.3
Aster DM Quality Care Ltd.Aster DM Quality Care Ltd.Healthcare770.31+4.6026,66,050109.665.967,9607.03880.53508.19+15.613.116.2
Narayana Hrudayalaya Ltd.Narayana Hrudayalaya Ltd.Healthcare1,935.54+4.577,84,73346.165.939,75742.022,082.151,562.32+11.419.916.2
Krishna Institute of Medical Sciences LtdKrishna Institute of Medical Sciences LtdHealthcare782.35+3.8410,43,652149.965.933,4835.22843.75569.07+19.411.011.5
Thyrocare Technologies Ltd.Thyrocare Technologies Ltd.Healthcare519.75+3.7390,96,95657.465.98,4149.06653.24337.10+0.929.138.3
Max Healthcare Institute Ltd.Max Healthcare Institute Ltd.Healthcare1,069.27+3.4495,32,00175.465.91,05,08014.191,174.97783.70-1.414.515.0
Granules India Ltd.Granules India Ltd.Healthcare814.19+3.4217,85,24928.841.922,46928.25914.15519.32+49.514.115.7
Abbott India Ltd.Abbott India Ltd.Healthcare26,383.62+3.0911,14233.941.956,378777.8230,505.4124,155.18-9.434.746.7
Lyka Labs Ltd.Lyka Labs Ltd.Healthcare92.71+2.431,50,497-77.341.9334-1.2092.7143.60+6.6-10.6-6.0
Ajanta Pharma Ltd.Ajanta Pharma Ltd.Healthcare3,292.19+2.2384,18832.741.941,445100.743,771.812,429.87+31.625.432.7
Sai Life Sciences Ltd.Sai Life Sciences Ltd.Healthcare1,790.22+2.166,17,773100.941.938,27217.751,933.71769.90+106.515.221.0
Torrent Pharmaceuticals Ltd.Torrent Pharmaceuticals Ltd.Healthcare4,636.17+2.092,00,05076.041.91,78,72761.025,146.453,649.74+22.026.819.3
Metropolis Healthcare Ltd.Metropolis Healthcare Ltd.Healthcare561.95+2.062,85,86651.965.911,74210.82601.60407.56+16.213.520.0
Glenmark Pharmaceuticals Ltd.Glenmark Pharmaceuticals Ltd.Healthcare2,618.55+2.055,40,18650.941.974,73351.432,671.171,797.30+40.214.120.4
Dr. Agarwal's Health Care Ltd.Dr. Agarwal's Health Care Ltd.Healthcare549.45+1.9586,095100.565.918,4025.47563.76393.44+5.98.716.1

Overview of Top Pharma Stocks

1

Themis Medicare Ltd.

Themis Medicare Ltd. started as a joint venture in 1969 between Themis and Gedeon Richter, a Hungarian pharmaceutical company. The company provides critical care, anti-infectives, anti-tuberculosis, and pain management treatments. It primarily aims to manufacture injectable formulations and drug-delivery systems with manufacturing facilities in Haridwar, Hyderabad, and Vapi. One of the company’s biggest brands was Metacin, a paracetamol.

2

IOL Chemicals and Pharmaceuticals Ltd.

IOL Chemicals and Pharmaceuticals Ltd. was established in 1986 in Punjab with an acetic acid manufacturing plant. The company engages in the manufacturing and sale of pharmaceutical products and special chemicals across domestic and international markets. One of the important operations of the company is its Active Pharma Ingredient, or API, and it is popular for its ibuprofen manufacturing and backwards-integrated production.

3

IND Swift Laboratories Ltd

IND Swift Laboratories Ltd. aims to deliver the top pharmaceutical products and services across domestic and international markets. It was established in Chandigarh in 1986, and later collaborated with Punjab State International Development Corporation (PSIDC) in 1995. The company focuses on ethical pharmaceuticals, generic formulations and exports, and transferred its API and contract research and manufacturing services to Synthimed Pvt. Ltd. in 2024.

4

Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd. entered the pharmaceutical industry in 1981, and later in 1995 it became a public limited company, supported by CEO Mr Bafna Mahaveer Chand. In 2011, it acquired Raricap from Johnson & Johnson’s Ltd and later sold the branded-generics business that included Raricap. The company manufactures and sells finished pharmaceutical products across domestic and international markets.

5

Global Health Ltd

Global Health Ltd. was incorporated in 2004 and later launched its brand Medanta in the year 2009. It was founded by Dr Naresh Trehan. It provides healthcare and medical delivery services, including cardiology, neurosciences, oncology, and digestive and kidney treatments. It has hospital facilities located across India, including Patna, Indore, Noida, Gurugram, Lucknow, and Ranchi, along with a few clinics.

What are pharma stocks?

Pharmaceutical equities represent ownership in companies that research, produce and distribute medicines and related healthcare products. In India, the ecosystem ranges from generics and vaccines to APIs, biosimilars, biologics and contract research and manufacturing, backed by about 3,000 drug companies and roughly 10.5K production units.

Its footprint shows up in supply and trade. India accounts for the world’s largest generic medicines and around 50-60% of vaccines. New capacity is also coming through CRDMO and CDMO providers and global capability centres, with about half of the leading life sciences multinationals running such hubs locally. As India targets a $30 trillion to $35 trillion economy by 2047, the blog ahead explains how to assess the top pharma stocks.

How to Invest in Pharma Sector Stocks?

You can invest in the pharma stocks, including the top pharma penny stocks to buy in India, in two broad ways, either by buying individual shares or by using a fund that tracks the sector. However, the right route depends on how much time you can spend on research & how concentrated you want your exposure to be.

  • Choose route: Buy individual pharma stocks or use a pharma ETF or index fund
  • Set up account: Open a demat and trading account, or use your mutual fund platform for funds
  • Build a shortlist: Select the companies based on your requirements. Check revenue sources, product mix, pipeline visibility, regulatory and quality record, recent results, debt and cash flows. Compare valuation with peers.
  • Monitor and review: Keep exposure sensible. Avoid making pharma your only theme. Add in stages and review after results and major regulatory updates.

Benefits of Investing in Pharma Stocks in India

Pharma can add a defensive tilt and global exposure to a portfolio, especially when you focus on quality businesses. Here are the key benefits often linked with the top pharma stocks in India:

  • Global relevance: Demand for medicines does not depend on one season or one trend. That can make the sector feel steadier than many discretionary areas.
  • More than one business model: The sector includes branded formulations, APIs and outsourced research and manufacturing via CRDMO and CDMO players. That variety gives investors more ways to participate.
  • Rising capability centres & digital work: Many large life sciences firms run global capability centres in India, pushing growth in analytics, automation and research support.
  • Strong manufacturing base: India has the largest number of manufacturing facilities compliant with U.S. Food and Drug Administration standards outside the US, plus over 500 API producers, which supports global supply chains.

Risks of Investing in Pharma Stocks

Pharma can be rewarding, but it comes with risks that can surprise first-time investors. If you are screening the top pharma stocks, these are the main ones to keep in mind.

  • Regulatory and quality risk: Adverse observations from regulators such as the USFDA can disrupt supplies and hit earnings.
  • Pricing pressure: Generic markets can face sharp price cuts, which can squeeze margins.
  • Export & currency exposure: A weaker or stronger rupee can change reported profits and competitiveness.
  • Input and supply chain swings: API costs, import dependence and logistics issues can affect production and profitability.
  • Policy & compliance changes: New rules from bodies such as SEBI or health authorities can alter reporting and business costs.

Factors to Consider Before Investing in Pharma Stocks

A structured checklist makes comparisons clearer and reduces avoidable mistakes. Use the points below to judge businesses on evidence, not headlines.

  • Revenue footprint: Map the split across India, the US and other regions, since pricing rules and compliance standards differ.
  • Therapy focus: Identify the main therapy areas and how crowded they are, because competition shapes staying power.
  • Product dependence: See whether earnings lean on a few brands or molecules, as concentration can amplify both gains and setbacks.
  • Regulatory record: Look beyond approvals and scan inspection history and corrective actions at key facilities.
  • Pipeline realism: Separate early plans from filed products, then gauge what is likely to reach the market on time.
  • Margin drivers: Track margin movement and explain it simply, for example, price changes, mix shift or cost pressures.
  • Cash and debt: Weigh operating cash flow, leverage and working capital discipline, especially when conditions tighten.
  • Valuation context: Compare price with growth and return metrics, since a low PE alone does not guarantee value.

Future of the Pharma Sector in India

By 2047, the medicines industry could reach a $450 billion market size. A study, based on stakeholder inputs gathered in September-October 2024, points to innovation & integrated healthcare as key engines of growth. It also notes that 79% of leaders see digital integration as pivotal for drug discovery and clinical development, alongside a push into next-generation therapies and connected care through the Ayushman Bharat Digital Mission.

Supply resilience remains central. 75% back sustainable manufacturing, 63% prioritise infrastructure and operational efficiency, and 38% highlight new materials and processes to move up the value chain.

Who Should Invest in Pharma Stocks

Pharma stocks may suit investors with a long time horizon who can handle price volatility and sector specific risks such as regulation and pricing pressure. They are typically better for people who are willing to track results and disclosures and who prefer adding limited exposure within a diversified portfolio.

Disclaimer

Please note that the above table is for informational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from third-party stock screeners and is subject to real-time updates.

Top Pharma Stocks in India FAQs

Which are the top 5 pharma stocks to watch today?

up
The top five pharma stocks to watch today are Jupiter Life Line Hospitals Ltd., Sigachi Industries Ltd., Nureca Ltd., Apollo Hospitals Enterprise Ltd., and Sakar Healthcare Ltd. This list is based on factors such as market capitalisation, financial performance, liquidity, and recent market data. It is for informational purposes only and is not a recommendation to buy, sell, or hold any of these stocks.

What are the top pharma companies in India?

up
The leading pharma companies in India include Jupiter Life Line Hospitals Ltd., Sigachi Industries Ltd., Nureca Ltd., Apollo Hospitals Enterprise Ltd., and Sakar Healthcare Ltd. These companies are among the prominent industry participants based on recent data. This is for informational purposes only and is not a recommendation to buy, sell, or hold any of these stocks.
Start Now